Suggestions

pharmaglobenews

pharmaglobenews

Progressive Fibrosing Interstitial Lung Disease Market Size in the 7MM is expected to grow at a significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Progressive Fibrosing Interstitial Lung Disease Market Insight, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding of Progressive Fibrosing Interstitial Lung Disease, historical and forecasted epidemiology as well as the Progressive Fibrosing Interstitial Lung Disease market trends in the
19 March 2026

Global Peanut Allergy Treatment Market Shows Rapid Expansion Toward USD 2.4 Billion by 2034 Amid Rising Prevalence and Breakthrough Immunotherapy Innovations

Peanut Allergy Treatment Market Overview Highlights Strong Growth Potential The global Peanut Allergy treatment market is witnessing substantial growth driven by increasing awareness, improved diagnostic methods, and expanding therapeutic options. According to current market analysis, the Peanut Allergy treatment market across the
19 March 2026

Peritoneal Carcinomatosis Market Forecast 2040: Epidemiology, Emerging Therapies, Clinical Trials, Key Companies, and Revenue Projections

DelveInsight’s “Peritoneal Carcinomatosis Market Insight, Epidemiology, and Market Forecast – 2040” report delivers a comprehensive analysis of the peritoneal carcinomatosis landscape, covering market dynamics, clinical development activities, and epidemiological trends. The report provides both historical and forecasted data alongside a detailed evaluation
19 March 2026

Sickle Cell Disease Market Set for Robust Expansion at a CAGR of 22.1% (2026–2034) Across 6MM, Driven by Rising Prevalence and Breakthrough Gene Therapies | DelveInsight

The Sickle Cell Disease (SCD) market is projected to experience remarkable growth through 2034, supported by increasing disease prevalence, improving diagnostic awareness, and rapid advancements in disease-modifying and gene-based therapies. According to DelveInsight, the market is expected to expand at a CAGR
19 March 2026

Myelodysplastic Syndrome Clinical Trial Pipeline Gains Momentum: 120+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Myelodysplastic Syndrome Pipeline Insights 2026” report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline landscape. It covers the Myelodysplastic Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myelodysplastic Syndrome pipeline therapeutics
13 March 2026
1 … 29 30 31 32 33 … 38

    Banner

    Newsletter